secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELI LILLY & Co (LLY)
CIK:        0000059478
Form:       8-K
Filed at:   2024-08-16T23:59:59+00:00
Accession:  0000059478-24-000196
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lilly director Marschall S. Runge to retire from board effective Aug. 31, 2024
------------------------------------------------------------------------------

- Runge served on board since 2013; retirement effective Aug. 31, 2024.
- No replacement named; departure not due to any disagreement with company.
- Runge also retiring as CEO of Michigan Medicine effective June 30, 2025; will remain on faculty.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/59478/000005947824000196/0000059478-24-000196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/59478/000005947824000196/lly-20240813.htm
  HTML page:      https://secwatch.observer/filing/0000059478-24-000196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer